The effect of sertraline with or without propranolol on the panic attack

Phase 3

Recruiting

• Conditions: Panic disorder.; Panic disorder [episodic paroxysmal anxiety] without agoraphobia; F41.0

• Registration Number: IRCT20120718010324N70
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Women with natural menopause
At least one year after amenorrhea
Women with researcher-diagnosed panic disorder (psychiatrist) based on diagnosis criteria (DSM-IV)
Sufficient literacy to complete the questionnaire or accompany a literate person in the family
Age minimum 40 years and maximum 60 years

Exclusion Criteria

Abuse of tobacco and alcohol
The occurrence of a stressful event (such as divorce, death of a first-degree family member, diagnosis of a terminal or incurable disease for a family member within the last three months, and job loss)
Systemic disorders (such as cardiovascular, diabetes, asthma, digestive, liver, blood, endocrine)
Taking antidepressants (such as antihistamines, barbiturates, narcotics, diazepam, amphetamines, and cocaine)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Panic attack. Timepoint: At the beginning of the study and 4 weeks after the start of consumption. Method of measurement: Panic Disorder Severity Scale – Self Report Form (PDSS-SR).

Secondary Outcome Measures

Name	Time	Method
Depression score. Timepoint: At the beginning of the study and 4 weeks after the start of consumption. Method of measurement: Beck Depression Inventory short form.